Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_004333.4(BRAF):c.111G>A (p.Ser37=)

CA175346

162804 (ClinVar)

Gene: BRAF (HGNC:673)

Condition: RASopathy (MONDO:0021060)

Inheritance Mode: Autosomal dominant inheritance

UUID: 7e872ce6-f7c9-4c3d-a39e-8a174058fd77

Approved on: 2017-04-03

Published on: 2018-12-10

HGVS expressions

NM_004333.4(BRAF):c.111G>A (p.Ser37=)

NM_004333.4:c.111G>A

NC_000007.14:g.140924593C>T

CM000669.2:g.140924593C>T

NC_000007.13:g.140624393C>T

CM000669.1:g.140624393C>T

NC_000007.12:g.140270862C>T

NG_007873.3:g.5172G>A

NM_001354609.1:c.111G>A

NM_004333.5:c.111G>A

NR_148928.1:n.336G>A

ENST00000288602.10:c.111G>A

ENST00000469930.1:n.117G>A

ENST00000497784.1:n.66G>A

Likely Benign

BP5 BP7

Evidence Links 0

Expert Panel

RASopathy VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

RASopathy VCEP

The c.111G>A (p.Ser37=) variant in BRAF is a synonymous (silent) variant at a nucleotide that is not highly conserved and is not predicted to impact splicing (BP7). This variant has been identified in a patient with an alternate molecular basis for disease (BP5; Partners LMM, GeneDx internal data, GTR ID's: SCV000197179.4, SCV000512270.5). In summary, this variant meets criteria to be classified as likely benign. RASopathy-specific ACMG/AMP criteria applied (PMID:29493581): BP7, BP5.

BP5

This variant has been identified in a patient with an alternate molecular basis for disease (BP5; Partners LMM, GeneDx internal data, GTR ID's: SCV000197179.4, SCV000512270.5).

BP7

The c.111G>A (p.Ser37=) variant is a synonymous (silent) variant at a nucleotide that is not highly conserved and is not predicted to impact splicing (BP7).

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.